戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              HFRS has prominent systemic manifestations.
2                                              HFRS is primarily a Eurasian disease, whereas HPS appear
3                                              HFRS patients have an activated coagulation system with
4                                              HFRS patients have increased thrombopoiesis and platelet
5                                              HFRS was associated with an increased risk of both in-ho
6                                              HFRS, baseline low, ORs: intermediate 2.65 [2.55, 2.75],
7 ociated with HPS [New York-1 virus (NY-1V)], HFRS [Hantaan virus (HTNV)], or by a hantavirus not asso
8 dmission in the eFI model 2.67 [2.55, 2.79], HFRS model 2.30 [2.20, 2.41], CCI model 2.62 [2.51, 2.75
9  Longitudinal samples were collected from 88 HFRS patients.
10 ate ratio of AMI/stroke in the 21 days after HFRS against 2 different control periods either excludin
11 xamined the risk of cancer development after HFRS in the Swedish population between 1997 and 2011 (n
12 nd stroke in the immediate time period after HFRS.
13 roke events occurred in the first week after HFRS.
14 th the highly virulent HCPS-causing ANDV and HFRS-causing PUUV, respectively.
15 ection by HPS causing Andes virus (ANDV) and HFRS causing Hantaan virus (HTNV) are inhibited by alpha
16 For predicting inpatient deaths, the CCI and HFRS based models were similar, however for longer term
17 opment as a countermeasure for both HCPS and HFRS, and its mode of Gn/Gc recognition informs the deve
18 98 blocked the cell entry of seven HCPS- and HFRS-associated hantaviruses, and single doses of this n
19 e findings indicate that pathogenic HPS- and HFRS-causing hantaviruses enter cells via beta3 integrin
20 -sectional study, using the population-based HFRS to screen for frailty yielded poor detection of fra
21                Adjusted associations between HFRS and in-hospital mortality and length of stay were c
22 a to humans or from human to human and cause HFRS and HCPS, with mortalities of 15% and 50%, respecti
23 us is an Old World hantavirus known to cause HFRS.
24                   We developed the cirrhosis-HFRS, a tool that demonstrates superior predictive accur
25 nd develop a simplified index, the cirrhosis-HFRS.
26                                 We collected HFRS patients' information and captured field and reside
27                      While the 109-component HFRS was associated with adverse surgical outcomes, 12 c
28   Increased circulating EVTF activity during HFRS is associated with intravascular coagulation.
29                  Plasma EVTF activity during HFRS is associated with intravascular coagulation.
30 TF activity was transiently increased during HFRS.
31 reased intravascular coagulation risk during HFRS, which could be due to platelet activation.
32 all indicate increased thrombopoiesis during HFRS.
33 et fraction, and mean platelet volume during HFRS.
34 enome sequences of Hantaan virus (HTNV) from HFRS patients and rodent hosts in endemic areas.
35  Risk Score [HFRS] < 5) and a frailty group (HFRS >= 5).
36  responses in 13 Finnish individuals who had HFRS between 1984 and 1995.
37 tails of pathogenic Andes (HPS) and Hantaan (HFRS) viruses are also degraded by the proteasome and th
38 ain findings of this study are that the high HFRS incidence (19.3/100,000) is correlated to the captu
39 66; 95% CI, 1.60-1.71) and those with higher HFRS scores (HR per 1.0-point increment, 1.10; 95% CI, 1
40                                     However, HFRS demonstrated the highest predictive value for adver
41 tly increased in vivo platelet activation in HFRS patients with intravascular coagulation (DIC and th
42 TE (grouped as intravascular coagulation) in HFRS patients.
43 TE (grouped as intravascular coagulation) in HFRS patients.
44 plementing targeted mitigation strategies in HFRS high-risk regions of the ROK.
45 erse surgical outcomes improved by including HFRS into the models.
46 ically, Jiangxi province has had the largest HFRS burden in China.
47          In univariate models for morbidity, HFRS demonstrated higher predictive discrimination (AURO
48 nce, and conducted a descriptive analysis of HFRS disease risks in the Republic of Korea (ROK).
49  that may contribute to immune components of HFRS disease.
50 his study is to determine the correlation of HFRS incidence with capture rate and hantavirus infectio
51                          The correlations of HFRS incidence to rodent capture rate and hantavirus inf
52  the spatiotemporal dynamics distribution of HFRS cases from 2005 to 2018 in Jiangxi at the county sc
53 nding of the spatiotemporal distributions of HFRS is limited in Jiangxi.
54 t, we demonstrate that the cellular entry of HFRS-associated hantaviruses is facilitated by specific
55 Jiangxi at the county scale. The epidemic of HFRS showed the characteristic of bi-peak seasonality, t
56          HTNV causes the most severe form of HFRS (5 to 15% case-fatality rate) and afflicts tens of
57 tect humans against the most severe forms of HFRS.
58 une), and the amplitude and the magnitude of HFRS outbreaks have been increasing.
59 e measures for the control and prevention of HFRS.
60 easomal degradation of the G1 tail in HPS or HFRS is unclear, these findings link G1 tail degradation
61         Risk assessment identified high-risk HFRS zones in northern Gyeonggi and Gangwon Provinces.
62             The Hospital Frailty Risk Score (HFRS) is a widely used measure of comorbidity burden in
63 Index (CCI) and Hospital Frailty Risk Score (HFRS) using specialist diagnoses during the preceding 5
64 rval]) for age, hospital frailty risk score (HFRS), electronic frailty index (eFI), Charlson comorbid
65 and include the Hospital Frailty Risk Score (HFRS), the Electronic Frailty Index (eFI), the 5-Factor
66 puted using the Hospital Frailty Risk Score (HFRS).
67 -frailty group (Hospital Frailty Risk Score [HFRS] < 5) and a frailty group (HFRS >= 5).
68 onal identification numbers from the Swedish HFRS patient database (1997-2012; n=6643) were cross-lin
69 ases haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS) in
70 cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), wi
71 mans: hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS).
72 cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) in humans.
73 lt in hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
74 ects, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
75 ases, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
76 ases: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
77 sult: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
78 ases, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
79 omes: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome.
80 ch as Hemorrhagic fever with Renal Syndrome (HFRS) and its mild form, Nephropathia Epidemica (NE), or
81 ) and hemorrhagic fever with renal syndrome (HFRS) are severe diseases associated with hantavirus inf
82 nt of hemorrhagic fever with renal syndrome (HFRS) in East Asia.
83 cause hemorrhagic fever with renal syndrome (HFRS) in Europe and Asia.
84 cause hemorrhagic fever with renal syndrome (HFRS) in humans.
85       Hemorrhagic fever with renal syndrome (HFRS) is a severe acute disease.
86 ither hemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome (HCPS) in h
87       Hemorrhagic fever with renal syndrome (HFRS) was considered to be transmitted by Apodemus agrar
88 auses hemorrhagic fever with renal syndrome (HFRS), which is an important public health problem in la
89  with hemorrhagic fever with renal syndrome (HFRS), which is caused by hantaviruses.
90 auses hemorrhagic fever with renal syndrome (HFRS).
91 ludes hemorrhagic fever with renal syndrome (HFRS).
92 ) and hemorrhagic fever with renal syndrome (HFRS).
93 auses hemorrhagic fever with renal syndrome (HFRS).
94                                          The HFRS (vs CFS) had a sensitivity of 27% and specificity o
95                                          The HFRS had the highest AUROC for estimating PACE during th
96                                          The HFRS was calculated using hospital administrative data.
97 nted for much of the association between the HFRS and mortality.
98 n endothelial cells and Vero E6 cells by the HFRS-causing hantaviruses Hantaan (HTN), Seoul (SEO), an
99    The optimal probability threshold for the HFRS was 1.4 points or higher.
100       These findings suggest that use of the HFRS in this population may result in important missed o
101 n was used to identify the components of the HFRS most predictive of mortality and develop a simplifi
102                 The higher risk areas of the HFRS outbreak were mainly located in Jiangxi northern hi
103  were the sensitivity and specificity of the HFRS to detect frail and nonfrail individuals according
104 was the optimal probability threshold of the HFRS to discriminate frail and nonfrail individuals.
105 ial autocorrelation analysis showed that the HFRS epidemic exhibited the characteristic of highly spa
106 set of 12 of the 109 ICD-10 codes within the HFRS resulted in superior prediction of mortality in thi
107                                   Therefore, HFRS patients should be carefully monitored during the a
108 to ACG criteria, 63 095 (71.3%) according to HFRS, and 76 754 (86.8%) according to PFI.
109 nd nonpathogenic hantaviruses, contribute to HFRS and HPS pathogenesis, and provide insight into dise
110 ccines or specific drugs to prevent or treat HFRS and HCPS and the requirement for conducting experim
111             However, it is not known whether HFRS is a risk factor for the acute cardiovascular event
112 and hip fracture was higher in patients with HFRS 5 and above (OR, 1.75; 95% CI, 1.31-2.33) and CKD (
113                                Patients with HFRS have an activated coagulation system with increased

 
Page Top